Clinicians should be prepared to discuss limited data for benefit of endocrine tx in ER-low positive cases.
A study evaluated contributions of physical and psychological symptoms, and pre-existing comorbidities to employment status following treatment for breast cancer.
A study of an Asian population failed to find a link between the virus and malignancies outside of the liver.
[Breast Cancer: Targets and Therapy] In this report, the researchers review the treatment of triple-negative breast cancer and specifically shed light on advances in immunotherapy and newly approved drugs for this challenging-to-manage disease.
Women largely do not know breast density ups risk for breast cancer even in U.S. states with notification.
Few differences seen between women residing in states that require notifications and those who do not.
False-negative rate lower for age-adjusted deep learning risk score versus density-based models.
Rates of mortality for invasive second breast cancer higher in those with prior radiotherapy for DCIS.
The US FDA has granted accelerated approval to Enhertu for the treatment of some adults with unresectable or metastatic HER2-positive breast cancer.
The researchers looked at what barriers may be contributing to low screening rates among women in Pima County in Southern Arizona.